Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NovaBay prices IPO

NovaBay (NBY; TSX:NBY) raised $20 million through the sale of 5 million shares

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE